MedPath

Clinical study of three ayurvedic formulations in fungal infection.

Phase 2
Not yet recruiting
Conditions
Local infection of the skin and subcutaneous tissue, unspecified. Ayurveda Condition: DADRU-KUSHTHAH,
Registration Number
CTRI/2021/08/035508
Lead Sponsor
Patanjali Ayurveda College
Brief Summary

In this trial, we are selecting patient of Dadru (Taenia corporis) in which we will do intervention in single group. We will intervene oral and local administration of ayurvedic drugs (Panchatikta Ghrita Guggulu, Khadirarishta, Edgajadi Lepa). Assessment will be done on basis of subjective & objective parameters.

Dose of medicine-

Panchatikta Ghrita Guggulu 2 tablets twice daily with luke warm water.

Khadirarishta 20 ml with equal amount of water twice daily.

Edgajadi Lepa  local application.

Route of administration- Panchatikta ghrita guggulu and Khadirarista orally, Edgajadi lepa local application.

Follow-up- The follow up will be done after 15 days and 1 month during the trial of 1 month to observe the effects of treatment or any adverse effects on patient.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria
  • a) Patient with signs and symptoms of Dadru and taenia corporis were included in the study.
  • b) Age group above 16 to 60 years randomly included for study.
  • c) Patients of both sex included for the study.
  • d) Patients having history of less than two years of onset of disease.
  • e) Both fresh and treated cases would be taken for the study.
Exclusion Criteria
  • a) Patients under long standing medication.
  • b) Pregnant women and lactating women.
  • c) Chronicity more than 2 years.
  • d) Age group below 16 years and above 60 years.
  • e) Patient suffering from uncontrolled DM.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Subject Parameter - Grading will be done considering signs and symptoms of dadru- Kandu, Raga,Pidika, UtsannamandalBefore intervention of the drugs for one month with Panchatikta Ghrita Guggulu and Khadirarishta orally,Edgajadi Lepa locally.
Objective Parameter-Before intervention of the drugs for one month with Panchatikta Ghrita Guggulu and Khadirarishta orally,Edgajadi Lepa locally.
Size of Mandal is assessedBefore intervention of the drugs for one month with Panchatikta Ghrita Guggulu and Khadirarishta orally,Edgajadi Lepa locally.
Secondary Outcome Measures
NameTimeMethod
Subject Parameter - Grading will be done considering signs and symptoms of dadru- Kandu, Raga,Pidika, UtsannamandalObjective Parameter-

Trial Locations

Locations (1)

PATANJALI AYURVED HOSPITAL

🇮🇳

Hardwar, UTTARANCHAL, India

PATANJALI AYURVED HOSPITAL
🇮🇳Hardwar, UTTARANCHAL, India
DR SHIVANI RAWAT
Principal investigator
8859865042
Shivanirawatofficial@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.